HUTCHMED (China) Ltd (HCM) stock
HCMNasdaqPharmaceutical PreparationsAlso trades as HMDCF
$13.22−0.23 (-1.71%)
Close on Nov 20, 2026Market cap $2.31BP/E 5.1Yield –
HUTCHMED (China) gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2025 it was $212.16M, down 24.6% from the year before. The highest annual figure on record is $453.55M in fiscal 2023.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $212.16M | -24.6% |
| FY2024 | Dec 31, 2024 | $281.32M | -38.0% |
| FY2023 | Dec 31, 2023 | $453.55M | +293.3% |
| FY2022 | Dec 31, 2022 | $115.31M | +61.4% |
| FY2017 | Dec 31, 2017 | $71.44M | +6.7% |
| FY2016 | Dec 31, 2016 | $66.95M | -8.7% |
| FY2015 | Dec 31, 2015 | $73.34M | +116.7% |
| FY2014 | Dec 31, 2014 | $33.85M | – |
See a number that looks wrong?